BioNTech SE (BNTX) Tops Q1 EPS by EUR0.04; big revenue miss

BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR0.79), EUR0.04 better than the analyst estimate of (EUR0.83). Revenue for the quarter came in at EUR167.7 million versus the consensus estimate of EUR607.8 million.

Still sees Covid-19 vaccine revenue about EUR5 billion, estimate EUR5.05 billion

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
• Cerebras CEO says investors misunderstood margin guidance
• Currenc Group suspends Indonesian WalletKu unit operations